Clinical trials for Rubella

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Rubella. For all clinical trials, go to clinical trials search

This list shows clinical trials for Rubella

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Rubella
Title Recruitment status Location
Baby Vaccine Study (Sched3) Not recruiting United Kingdom
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants Not recruiting United Kingdom
The DECIDA study: Detailed Evaluation of a Childhood Immunisation Decision Aid Not Recruiting United Kingdom
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ dTpa-IPV vaccine (Boostrix Polio) compared with Sanofi Pasteur MSD’s dTpa-IPV vaccine (Repevax), when co-administered with GSK Biologicals’ MMR vaccine (Priorix) in 3 and 4-year-old healthy children. - DTPA-IPV (BOOSTRIX-IPV)-009 Authorised United Kingdom
A Study of the Interaction between BCG And Meningitis C immunisation: BAM Authorised United Kingdom
Clinical study to compare the immune response and safety of vaccine for prevention of Measles and Rubella diseases (MR vaccine) manufactured by Cadila Healthcare Ltd. with MR vaccine manufactured by Serum Institute of India Ltd. in children 9-12 months of age Recruiting India
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant Recruiting United States
The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants Recruiting Israel
Safety and efficacy of live attenuated vaccine in patients received hematopoietic stem cell transplantation Recruiting Japan
Measles-Rebella vaccination study. Recruiting Iran, Islamic Republic Of

Page last reviewed: 03/11/2015

Next review due: 01/11/2018